Company news

Karyopharm Therapeutics Inc. news in 2025

Karyopharm Therapeutics Inc.'s news releases, calls and decks from 2025, newest first.

View company

Karyopharm to Participate in Baird's Biotech Discovery Series

December 8, 2025

Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference

December 1, 2025

Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress

November 3, 2025

Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025

October 27, 2025

Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis

October 8, 2025

Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis

September 10, 2025

Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress

August 11, 2025

Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025

August 5, 2025

Karyopharm to Present at the Jefferies Global Healthcare Conference

June 3, 2025

Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference

May 19, 2025

Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting

May 14, 2025

Karyopharm Reports First Quarter 2025 Financial Results and Announces New Data in Myelofibrosis that Further Suggests Selinexor May Lead to Meaningful Spleen Volume Reduction, Symptom Improvement, Hemoglobin Stabilization and Disease Modification

May 12, 2025

Karyopharm to Report First Quarter 2025 Financial Results on May 12, 2025

May 8, 2025

Karyopharm Announces 1-for-15 Reverse Stock Split

February 24, 2025

Karyopharm Reports Fourth Quarter and Full Year 2024 Financial Results, Announces Update to Phase 3 XPORT-EC-042 Trial and Highlights Recent Company Progress

February 19, 2025

Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

February 11, 2025

Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives

January 12, 2025

Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer

January 1, 2025

Calls in 2025

Decks in 2025